BR-790
- Generic Name
- BR-790
A Phase I Study of BR790 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2021-05-18
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04891653
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath